Medical Research Future Fund (MRFF) Awards July – December 2018

MRFF Fellowships

john zalcberg

Prof John Zalcberg, Professor of Cancer Research, Department of Epidemiology and Preventive Medicine, Monash University

A national cancer outcome strategy ($487,893.00)

andrew wei

A/Prof Andrew Wei, Head of Leukaemia Research, Australian Centre for Blood Diseases, Monash University and Alfred Health

Translational Research Program to Advance Clinical Outcomes in Acute Myeloid Leukaemia ($412,419)

jake shortt

A/Prof Jake Shortt, Head of Haematology Research, School of Clinical Sciences, Monash University and Monash Health

Next generation targeting of DNA methylation in poor risk lymphoid cancer ($ 218,518)

karen alt

Dr Karen Alt, Senior Researcher, Australian Centre for Blood Diseases, Monash University

Novel targeted oncotheranostic nanoparticles for personalised therapy and real-time monitoring ($431,000)

 

MRFF Clinical Trials

andrew spencer

Prof Andrew Spencer, Head of the Malignant Haematology & Stem Cell Transplantation Service, Alfred Health

Frailty-stratified randomised controlled bayesian adaptive trial of bortezomib versus lenalidomide in transplant-ineligible myeloma – the FRAIL-M study ($1,682,835)

Andrew Perkins

Prof Andrew Perkins, Head of the Blood Cancer Genomics Lab, Australian Centre for Blood Diseases, Monash University

Improving survival in myelofibrosis ($1,733,327)

erica wood

Prof Erica Wood, Head of the Transfusion Research Unit, School of Public Health and Preventive Medicine, Monash University

The DIAAMOND study: Diagnosis of aplastic anaemia, management, and outcomes utilising a national dataset ($ 1,750,726)

andrew wei

A/Prof Andrew Wei, Head of Leukaemia Research, Australian Centre for Blood Diseases, Monash University and Alfred Health

A registry-linked national platform trial to improve precision-based outcomes using novel therapies in acute myeloid leukemia (AML) ($1,507,785)

2018-12-13T06:34:14+00:00 December 12th, 2018|